注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Cardiff Oncology Inc是一家临床阶段生物技术公司。该公司专注于为癌症患者开发治疗方案。其候选药物onvansertib是一种polo样激酶1(PLK1)三磷酸腺苷(ATP)竞争性抑制剂,结合化疗和靶向治疗。其临床试验包括TROV-054、CRDF-001和TROV-053。TROV-054是onvansertib联合FOLFIRI(叶酸、氟尿嘧啶和irinotecan)和Avastin(bevacizumab)的I期b/2开放标签临床试验。TROV-053是onvansertib联合Zytiga(abiraterone acetate)/强的松的II期开放标签临床试验。CRDF-001是onvansertib联合纳米脂质体irinotecan、亚叶酸和氟尿嘧啶治疗转移性胰腺导管腺癌(mPDAC)患者的2期开放标签多中心临床试验。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Sandra L. Silberman | 65 | 2017 | Member of Clinical Advisory Board |
Filip Janku | 47 | - | Member of Clinical Advisory Board |
Emmanuel Antonarakis | - | 2020 | Member of Clinical Advisory Board |
Mark Erlander | 61 | 2013 | CEO & Director |
Rodney S. Markin | 64 | 2014 | Independent Chairman of the Board |
Gary W. Pace | 73 | 2020 | Independent Director |
Renee P. Tannenbaum | 70 | 2021 | Independent Director |
Lale White | 66 | 2020 | Independent Director |
Carlo Maria Croce | - | - | Member of Scientific Advisory Board |
Paul R. Billings | 70 | 2012 | Member of Scientific Advisory Board |
Charles R. Cantor | 79 | - | Member of Scientific Advisory Board |
Michael B. Yaffe | - | 2018 | Member of Clinical Advisory Board |
Glenn J. Bubley | - | 2018 | Member of Clinical Advisory Board |
Heinz-Josef Lenz | 62 | 2020 | Member of Clinical Advisory Board |
Alberto Bardelli | - | 2014 | Member of Scientific Advisory Board |
Brunangelo Falini | - | 2010 | Member of Scientific Advisory Board |
K. Peter Hirth | 70 | 2014 | Member of Scientific Advisory Board |
James O. Armitage | 75 | 2020 | Independent Director |
Mani Mohindru | 50 | 2021 | Independent Director |
Amer Zeidan | - | 2020 | Member of Clinical Advisory Board |
Riccardo Dalla-Favera | 70 | 2010 | Member of Scientific Advisory Board |
David Einstein | - | 2018 | Member of Clinical Advisory Board |
Eric Van-Cutsem | - | - | Member of Scientific Advisory Board |
Adam Schayowitz | - | - | Member of Scientific Advisory Board |
Christoph Reinhard | - | - | Member of Scientific Advisory Board |
Josep Tabernero | - | - | Member of Scientific Advisory Board |
Scott Kopetz | - | - | Member of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核